FDA clears Stimwave’s Freedom Spinal Cord Stimulator System

Stimwave received FDA clearance for the first injectable wireless microsize pain relief system.

Advertisement

The device is currently marketed throughout Europe, and now approved for marketing in the United States. The Stimwave Freedom Spinal Cord Stimulator System. It is the smallest neuromodulation device available.

 

There is a tiny injectable microchip device to deliver small pulses of energy to electrodes near surrounding nerves to trigger a reaction that enables the brain to remap specific pain signals.

 

More articles on orthopedic devices:
Orthopedic & spine device company stock report: 5 key updates—Dec. 1
FTC, EU approve Medtronic’s acquisition of Covidien—8 things to know
10 key thoughts on the spinal non-fusion device market

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.